Clinical trial
The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese…
NCT00459056 · St. Paul Heart Clinic, Other · Completed
Key facts
| NCT number | NCT00459056 |
|---|---|
| Title | The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients |
| Official title | The Vascular Effects of Carvedilol Controlle Release (CR) + Lisinopril Versus Lisinopril + Hydrochlorothiazide (HCTZ) in Abdominally Obese Hypertensive Patients |
| Lead sponsor | St. Paul Heart Clinic, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Abdominal Obesity, Hypertension |
| Intervention type | Drug |
| Interventions | Carvedilol CR + Lisinopril, Lisinopril + HCTZ |
| Enrollment | 25 |
| Start date | Apr 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Apr 11, 2007 |
| Last update posted | Dec 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: